Brenntag, the global leader in chemicals and ingredients distribution, has signed an exclusive distribution agreement with Henan Yongchang Nitro Fertilizer Co., Ltd. for nitric acid, covering the markets of Australia and New Zealand. Henan Yongchang is a long-established chemical producer based in Huixian City in …
Transcenta Holding Limited, a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc., a glob…
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity investment from Eli Lilly and Company ("Lilly"). ABL Bio and Li…
Pfizer India and Cipla Limited announced a partnership where Cipla will exclusively market and distribute four brands of Pfizer in India. Under the agreement, Cipla now has the sole right to market, distribute and sell the cough syrup Corex Dx and Corex LS, the non-steroidal anti-inflammatory drug (NSAID) Dolonex, th…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology Co., Ltd. ("Lannacheng"). The two parties will lever…
Sanofi announced that it has entered into an agreement to acquire Dynavax Technologies Corporation, a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and a differentiated shingles vaccine candidate. The acquisition augments Sanofi's presence in adult immunization by bringing to…
Solventum announced it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered materials for regenerative wound care. "Announcing and completing our first strategic acquisition is a significant milestone and the successful…
BioMarin Pharmaceutical Inc. and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an all-cash transaction for a total equity value of approximately $4.8 billion. The agreement has been unanimously approved by the Boards of Directors of both c…
Niowave Inc., a U.S.- based global leader in medical radioisotope production, announced the expansion of its existing supply agreement with AstraZeneca, a global biopharmaceutical company, to a 10-year commitment to deliver Actinium-225 (Ac-225), following AstraZeneca's decision to exercise its option to increase capa…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodi…
Page 21 of 37